Management of atrial fibrillation in patients with structural heart disease.
about
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart LesionsManagement Of Atrial Fibrillation In Patients With Heart FailurePitx2 modulates a Tbx5-dependent gene regulatory network to maintain atrial rhythm.Atrial Fibrillation in the Young: A Neurologist's NightmareBioptic Study of Left and Right Atrial Interstitium in Cardiac Patients with and without Atrial Fibrillation: Interatrial but Not Rhythm-Based Differences.Differences in atrial fibrillation‑associated proteins between the left and right atrial appendages from patients with rheumatic mitral valve disease: A comparative proteomic analysis.Individualized therapy in patients with atrial fibrillation: new look at atrial fibrillation.Medical emergencies: atrial fibrillation and myocardial infarction.Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality.Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases.Tachyarrhythmias and catheter ablation in adult congenital heart disease.Computational fluid dynamics modelling of left valvular heart diseases during atrial fibrillation.Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry.Atrial fibrillation ablation using remote magnetic navigation and the risk of atrial-esophageal fistula: international multicenter experience.Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation.Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey.The impact of cardiac rhythm on the mitral valve area and gradient in patients with mitral stenosis.Report on the Ion Channel Symposium : Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18).
P2860
Q26764853-B3BA4ECD-C743-481C-A5D7-21EB19334DFBQ30354835-2B478910-4C1F-463D-A8A1-CA06DE0BD5BEQ30836496-579BC833-3787-45B4-B5B9-B5D28CF40A57Q35438395-F02026F6-9688-4FCD-B9D5-94780025128CQ35661373-9FA5DDAC-0E70-4E88-A08A-47CACA2E25F5Q37403391-22B07077-53BB-47A4-A53C-4DB742A840DEQ38056112-BC231BEB-9153-47ED-9442-AC1F87DF0181Q38064908-A98EFDD5-1717-4404-87DE-AA54F7DF5FAAQ38144996-C329F724-866D-42DD-A994-743AD1F90A36Q38188453-3EDC1549-7BB0-4C03-94FD-704D004D1E69Q38208370-F5221DE2-ED54-4B4E-8771-8572E39DE86BQ38377941-48EF20FA-FD0A-426A-A7A4-21F5781133EEQ38384634-6760A235-20FE-483F-B15C-C15CEE4D9A40Q38947661-73E730DC-9BA4-480C-86F7-11D9C8C68ED2Q40984824-DB9020CB-9075-426C-9BF0-25A579FBB683Q41043278-074C011A-0926-4D28-BE0F-759FC3F91D1BQ46731211-F907D6C2-6DFC-461A-BDA0-F7611BF74627Q47096794-CB4FE1D3-CF9D-4D7A-BF38-088F6C109D5DQ48522025-3974DA60-235B-4FAE-9F97-A8DDBA568E58
P2860
Management of atrial fibrillation in patients with structural heart disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Management of atrial fibrillation in patients with structural heart disease.
@ast
Management of atrial fibrillation in patients with structural heart disease.
@en
type
label
Management of atrial fibrillation in patients with structural heart disease.
@ast
Management of atrial fibrillation in patients with structural heart disease.
@en
prefLabel
Management of atrial fibrillation in patients with structural heart disease.
@ast
Management of atrial fibrillation in patients with structural heart disease.
@en
P1433
P1476
Management of atrial fibrillation in patients with structural heart disease.
@en
P2093
Andrew E Darby
John P Dimarco
P304
P356
10.1161/CIRCULATIONAHA.111.019935
P407
P577
2012-02-01T00:00:00Z